Aspen Pharmacare Holdings Ltd
(JSE:APN)
R
239.58
-4.69 (-1.92%)
Market Cap: 106.43 Bil
Enterprise Value: 130.95 Bil
PE Ratio: 22.29
PB Ratio: 1.27
GF Score: 79/100 - Aspen Pharmacare Holdings Ltd Manufacturing Day and site visit 2023 SESSION 3 TranscriptNov 29, 2023
- Aspen Pharmacare Holdings Ltd Manufacturing Day and site visit 2023 Session 1 TranscriptNov 29, 2023
- Full Year 2023 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptAug 31, 2023R172.2 (+0.50%)Earnings
- Half Year 2023 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 02, 2023R168.74 (+4.97%)Earnings
- Full Year 2022 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 01, 2022R156.89 (+6.37%)Earnings
- Half Year 2022 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 10, 2022R173.93 (-5.25%)Earnings
- Aspen Pharmacare Holdings Ltd Aspen Confirms Non-Binding Term Sheet on Manufacture And Sale of an Aspen Branded COVID-19 vaccine Throughout Africa Call TranscriptNov 30, 2021
- Full Year 2021 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 02, 2021R199.9 (+4.93%)Earnings
- Half Year 2021 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 12, 2021R149.95 (-0.70%)Earnings
- Aspen Pharmacare Holdings Ltd Virtual Investor Day TranscriptDec 11, 2020
- Full Year 2020 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 10, 2020R131.54 (-5.67%)Earnings
- Half Year 2020 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptMar 06, 2020
- Full Year 2019 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptSep 12, 2019
- Half Year 2019 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptMar 08, 2019
Half Year 2020 Aspen Pharmacare Holdings Ltd Earnings Presentation Transcript
Mar 06, 2020 / 06:30AM GMT
Release Date Price:
R107.75
(-2.05%)
Alex Robert John Comer
JP Morgan Chase & Co, Research Division - Research Analyst
Presentation
Mar 06, 2020 / 06:30AM GMT
=====================
Corporate Participants
=====================
* Michael Guy Attridge
Aspen Pharmacare Holdings Limited - Deputy Group Chief Executive, Finance Director & Executive Director
* Stephen Bradley Saad
Aspen Pharmacare Holdings Limited - Group CEO & Executive Director
=====================
Conference Call Participants
=====================
* Alex Robert John Comer
JP Morgan Chase & Co, Research Division - Research Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)